Haddad RI - Search Results

1

Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer.

Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano PJ, Zha Y, Zapaishchykova A, Likitlersuang J, Guthier C, Tishler RB, Schoenfeld JD, Margalit DN, Haddad RI, Mak RH, Naser M, Wahid KA, Sahlsten J, Jaskari J, Kaski K, Mäkitie AA, Fuller CD, Aerts HJWL, Kann BH. Ye Z, et al. Among authors: haddad ri. JAMA Netw Open. 2023 Aug 1;6(8):e2328280. doi: 10.1001/jamanetworkopen.2023.28280. JAMA Netw Open. 2023. PMID: 37561460 Free PMC article.

2

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Haddad R, et al. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. Cancer. 2003. PMID: 12518365 Free article.

3

Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR. Haddad R, et al. Oncologist. 2003;8(1):35-44. doi: 10.1634/theoncologist.8-1-35. Oncologist. 2003. PMID: 12604730 Free article. Review.

4

Nonsurgical treatment of laryngeal cancer.

Haddad RI, Tishler RB, Posner MR. Haddad RI, et al. N Engl J Med. 2004 Mar 4;350(10):1049-53; author reply 1049-53. N Engl J Med. 2004. PMID: 15002117 No abstract available.

5

Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.

McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, Posner MR, Van den Abbeele AD. McCollum AD, et al. Among authors: haddad ri. Head Neck. 2004 Oct;26(10):890-6. doi: 10.1002/hed.20080. Head Neck. 2004. PMID: 15390197

6

Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancer.

Sullivan CA, Jaklitsch MT, Haddad R, Goguen LA, Gagne A, Wirth LJ, Posner MR, Tishler RB, Norris CM. Sullivan CA, et al. Laryngoscope. 2004 Nov;114(11):1924-31. doi: 10.1097/01.mlg.0000147921.74110.ee. Laryngoscope. 2004. PMID: 15510015

7

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, Sullivan C, Tishler RB. Posner MR, et al. Among authors: haddad ri. Semin Oncol. 2004 Dec;31(6):778-85. doi: 10.1053/j.seminoncol.2004.09.007. Semin Oncol. 2004. PMID: 15599855 Review.

8

Chemoradiation-induced cell loss in human submandibular glands.

Sullivan CA, Haddad RI, Tishler RB, Mahadevan A, Krane JF. Sullivan CA, et al. Among authors: haddad ri. Laryngoscope. 2005 Jun;115(6):958-64. doi: 10.1097/01.MLG.0000163340.90211.87. Laryngoscope. 2005. PMID: 15933500

9

Integrating novel agents into the curative treatment of head and neck cancer.

Haddad R, Allen A, Wirth L, Tishler R, Posner M. Haddad R, et al. Expert Rev Anticancer Ther. 2006 Feb;6(2):157-9. doi: 10.1586/14737140.6.2.157. Expert Rev Anticancer Ther. 2006. PMID: 16445367 No abstract available.

10

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.

Haddad RI, Posner MR, Busse PM, Norris CM Jr, Goguen LA, Wirth LJ, Blinder R, Krane JF, Tishler RB. Haddad RI, et al. Am J Clin Oncol. 2006 Apr;29(2):153-7. doi: 10.1097/01.coc.0000203756.36866.17. Am J Clin Oncol. 2006. PMID: 16601434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page